BioSante added to NASDAQ Biotechnology Index
November 21, 2011 by leonardzehr · Leave a Comment
BioSante Pharmaceuticals (NASDAQ:BPAX) has been added to the NASDAQ Biotechnology Index, effective prior to the stock market open today.
“We are delighted that BioSante has been added to the NASDAQ Biotechnology Index, as it recognizes our established role in the biotechnology industry, adds greater visibility for our company and could lead to a broader stockholder base,” CFO Phillip Donenberg said in a statement.
The NASDAQ Biotechnology Index is a modified market capitalization-weighted index, and the index securities are evaluated semi-annually in May and November.
Listen to BioTuesdays 
